Unselected solid tumors dose escalation
Showing 1 - 25 of >10,000
Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)
Not yet recruiting
- Solid Tumors
- Rimiducid
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 27, 2023
HER-2 Positive Advanced Solid Tumors Trial (D3L-001)
Not yet recruiting
- HER-2 Positive Advanced Solid Tumors
- D3L-001
- (no location specified)
Jul 20, 2023
Unresectable or Metastatic Advanced Solid Tumors Trial (WTX212A)
Not yet recruiting
- Unresectable or Metastatic Advanced Solid Tumors
- (no location specified)
Sep 6, 2023
Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)
Not yet recruiting
- Solid Tumor, Adult
- CF33-CD19 IT
- +2 more
- (no location specified)
Sep 26, 2023
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)
Recruiting
- Colon Cancer
- Chimeric antigen receptor T cell preparation targeting GCC
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 16, 2023
Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)
Not yet recruiting
- Locally Advanced Solid Tumors
- +2 more
- (no location specified)
Sep 4, 2023
Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)
Not yet recruiting
- Recurrent or Metastatic Solid Tumors
- Recombinant Anti-EpCAM-CD3 Antibody Injection
- (no location specified)
Oct 17, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Advanced Solid Tumor Trial in Beijing (QLS12004)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaThe Fifth Medical Center of the General Hospital of the Chinese
Apr 13, 2023
Advanced Solid Tumors Trial (ASKG915)
Not yet recruiting
- Advanced Solid Tumors
- ASKG915
- (no location specified)
May 10, 2023
Advanced Solid Tumors Trial in Beijing (WJB001)
Not yet recruiting
- Advanced Solid Tumors
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I
Not yet recruiting
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Phase I dose escalation
- +3 more
-
Shanghai, Shanghai, ChinaFudan Cancer Hospital
Apr 24, 2023
Advanced Solid Tumor Trial in Beijing (BA1202)
Not yet recruiting
- Advanced Solid Tumor
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jun 18, 2023
Advanced Solid Tumor Trial in Shanghai (HY-0102)
Not yet recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 19, 2023
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023
Cancer Trial in Singapore (YS-0N-001)
Recruiting
- Cancer
- YS-0N-001
-
Singapore, SingaporeNational University Cancer Institute Singapore
Dec 20, 2022
Advanced Solid Tumor Trial (AM-928)
Not yet recruiting
- Advanced Solid Tumor
- AM-928
- (no location specified)
Jan 7, 2023
Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)
Withdrawn
- Relapsed Solid Neoplasm
- +2 more
- STI-3258
- (no location specified)
Jan 24, 2023